Adjuvant chemotherapy for resectable non-small-cell lung cancer: Where is it going?

Annals of Oncology

Volumn 21, Issue SUPPL. 7, 2010, Pages

  Le Chevalier, T ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adjuvant chemotherapy; Adjuvant radiotherapy; Meta analysis; Non small cell lung carcinoma; Randomized controlled trials; Systematic review

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MITOMYCIN C; NAVELBINE; PACLITAXEL; UFT; VINBLASTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; META-ANALYSIS AS TOPIC;

EID: 78649343573     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq376     Document Type: Conference Paper

References (13)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995; 311: 899-909.
2. Keller SM, Adak S, Wagner S et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA NSCLC. N Engl J Med 2000; 343: 1217-1222.
3. Scagliotti GV, Fossati R, Torri V et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 2003; 95: 1453-1461.
4. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-360.
5. Olaussen KA, Dunant A, Fouret P et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006; 355: 983-991.
6. Waller D, Peake MD, Stephens RJ et al. Chemotherapy for patients with non-small cell lung cancer. The surgical setting of the Big Lung Trial. Eur J Cardio-Thoracic Surgery 2004; 26: 173-182.
7. Kato H, Ichinose Y, Ohta M et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004; 350: 1713-1721.
8. Winton TL, Livingston R, Johnson D et al. Vinorelbine plus cisplatin vs observation in resected non-small cell lung cancer. N Engl J Med 2005; 352: 2589-2597.
9. Strauss GM, Herndon J, Maddaus MA et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) Protocol 9633. Proc Am Soc Clin Oncol 2006; Abstr 7007.
10. Douillard JY, Rosell R, De Lena M et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006; 7: 719-727.
11. Pignon JP, Tribodet H, Scagliotti GV et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008; 26: 21: 3552-3555.
12. Douillard JY, Tribodet H, His P et al. Lung adjuvant cisplatin evaluation (LACE vinorelbine project) pooled analysis of adjuvant vinorelbine-cisplain trials for completely resected non-small cell lung cancer. Proceedings of the European Society for Molecular Oncology 2006; Abstr 7100.
13. Stewart LA, Burdett S, Tierney JF et al. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT). J Clin Oncol 2007; 25: 7552.